Abeona Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	61.37	78.44	23.36	14.47	14.22	32.94
Short-Term Investments	106.9	112.97	74.36	37.75	37.93	12.09
Cash & Short-Term Investments	168.27	191.4	97.72	52.23	52.15	45.02
Cash Growth	99.95%	95.87%	87.11%	0.15%	15.82%	-52.62%
Accounts Receivable	6.2	6.15	-	-	-	3
Other Receivables	0.51	0.57	1.65	2.44	0.19	-
Total Trade Receivables	6.71	6.72	1.65	2.44	0.19	3
Inventory	6.05	5.49	-	-	-	-
Other Current Assets	1.95	1.29	1.48	1.07	0.76	8.27
Total Current Assets	182.99	204.91	100.85	55.74	53.1	56.29
Net Property, Plant & Equipment	14.68	13.88	7.98	7.99	11.07	21.74
Other Intangible Assets	-	-	-	-	-	1.38
Other Long-Term Assets	0.83	0.78	0.1	0.28	0.04	0.17
Total Assets	198.49	219.57	108.93	64	64.21	79.59
Accounts Payable	4.07	7.89	3.44	1.86	1.81	4.33
Accrued Expenses	5.37	8.59	6.33	5.99	3.99	5.59
Current Portion of Long-Term Debt	13.33	12.22	5.93	-	-	-
Current Portion of Leases	1.27	0.86	0.82	1	1.77	1.82
Other Current Liabilities	7	0	0.06	4.58	0.2	4.9
Total Current Liabilities	31.05	29.57	16.59	13.42	7.78	16.62
Long-Term Debt	4.75	7.81	13.04	-	-	-
Long-Term Leases	3.81	4.07	3.26	4.4	5.85	7.56
Other Long-Term Liabilities	13.94	18.9	32.01	31.35	23.82	13.04
Total Long-Term Liabilities	22.51	30.78	48.31	35.75	29.67	20.6
Total Liabilities	53.56	60.35	64.9	49.18	37.45	37.22
Common Stock	0.57	0.55	0.46	0.27	0.18	1.47
Additional Paid-in Capital	903.54	900.6	856.82	764.15	722.05	696.56
Accumulated Other Comprehensive Income	-0.02	0.14	0.01	-0.07	-0.13	-0.03
Retained Earnings	-759.15	-742.08	-813.26	-749.52	-695.34	-655.64
Shareholders' Equity	144.94	159.22	44.03	14.83	26.76	42.37
Total Liabilities & Equity	198.49	219.57	108.93	64	64.21	79.59
Total Debt	23.17	24.97	23.05	5.4	7.63	9.38
Net Cash (Debt)	145.1	166.44	74.67	46.83	44.52	35.65
Net Cash Growth	-12.82%	122.89%	59.47%	5.17%	24.90%	-58.70%
Net Cash Per Share	2.37	2.52	1.82	2.19	5.66	9.05
Book Value	144.94	159.22	44.03	14.83	26.76	42.37
Book Value Per Share	2.37	2.41	1.07	0.69	3.40	10.76
Tangible Book Value	144.94	159.22	44.03	14.83	26.76	40.98
Tangible Book Value Per Share	2.37	2.41	1.07	0.69	3.40	10.41

SEC Filings: 10-K · 10-Q